ProMIS Neurosciences (PMN) Live Share Price, Invest From India

ProMIS Neurosciences Stock Performance

as on October 14, 2026 at 6:57 am IST

Day's Low
Day's High
$8.51
Day's Price Range
$9.47
$8.88
4.17%
Downside
6.64%
Upside
52 Week's Low
52 Week's High
$6.27
52-Week Price Range
$27.40
$8.88
29.39%
Downside
208.56%
Upside

ProMIS Neurosciences share price movements today

Previous Close: $9.45
Open: $9.35
Volume: 230.9K
Market Cap: $84.7M
Day's Low - High: $8.51 - $9.47
52 Week Low - High: $6.27 - $27.40

ProMIS Neurosciences Historical Returns

1 Month Return: -30.31 %
3 Month Return: -26.17 %
1 Year Return: -21.25 %
3 Year Return: -79.57 %
5 Year Return: 0 %

ProMIS Neurosciences Stock Fundamentals & Key Indicators

Check ProMIS Neurosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$84.7M

EPS (TTM)

-16.89

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.57

Industry PE ratio

-3.05

PEG Ratio

0.00

EBITDA

-42.7M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-143.09%

ProMIS Neurosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ProMIS Neurosciences with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
ProMIS Neurosciences	Buy	$84.7M	NA	-0.57	0.00%	0.00%
Moderna	Neutral	$89.8B	-33.52%	-28.20	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$129.3B	179.59%	29.45	86.04%	0.00%
Regeneron	Buy	$76.9B	39.42%	17.83	84.86%	0.50%

Stock Returns calculator for ProMIS Neurosciences Stock including INR - Dollar returns

The ProMIS Neurosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

ProMIS Neurosciences investment value today

Current value as on today

₹79,513

Returns

-₹20,487

(-20.49%)

Returns from ProMIS Neurosciences Stock

-₹26,000 (-26%)

Dollar Impact

₹5,513 (+5.51%)

Analyst Recommendation on ProMIS Neurosciences Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for ProMIS Neurosciences. Average target price of $42.48

ProMIS Neurosciences Share Price Target

Get share price movements and forecasts by analysts on ProMIS Neurosciences.

What analysts predicted

79.1%UPSIDE

Target Price

$42.48

Current Price

$8.88

Analyzed by

2 Analysts

High

$100

Target

$42.48

Low

$18

ProMIS Neurosciences target price $42.48, a slight upside of 79.1% compared to current price of $8.88. According to 2 analysts rating.

Indian Investors' Interest in ProMIS Neurosciences Stock

Search interest for ProMIS Neurosciences Stock has decreased by -69% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 14, 2026 to October 14, 2026

Change:-69% versus previous 30 day period

ProMIS Neurosciences Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	-	-	-	-	-	-	-	-	-
Operating Income	-3	-3	-2	-4	-7	-10	-11	-10	-8	-12
EBITDA	-3	-3	-2	9	-7	-10	-11	-10	-8	-11
Interest Expense	0	0	-	-	-	-	-	-	-	-
Depreciation	0	-	-	-	-	-	-	-	-	-
Income Before Tax	-3	-3	-2	9	-7	-10	-11	-10	-8	-11
Income Tax Expense	-	-	-	-	-	-	-	-	-	-
Net Income	-3	-3	-2	9	-7	-10	-11	-10	-8	-11
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

ProMIS Neurosciences Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Mar 2021	Dec 2022	Dec 2023	Mar 2025	Dec 2025
Total Revenue	0	0	-	-	-	-
Gross Profit	-4	-3	-	-10	-	-
Operating Income	-12	-5	-23	-18	-16	-40
EBITDA	-7	-5	-17	-17	2	-39
Interest Expense	-	-	0	0	0	-
Depreciation	0	0	0	0	-	-
Income Before Tax	-7	-5	-18	-17	2	-39
Income Tax Expense	-	-	-	-	-	-
Net Income	-7	-5	-18	-17	2	-39
Net Profit Margin	-393853.16%	-203296.10%	0.00%	0.00%	0.00%	0.00%

ProMIS Neurosciences Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-3	-3	-2	9	-7	-10	-11	-39,690	-8	-11
Operating Cash Flow	-3	-10	-1	-6	-4	-3	-10	-9	-12	-10
Investing Cash Flow	0	-	-	-	-	-	-	0	-	-
Financing Cash Flow	0	0	-	27	-	-	21	0	70	-
Change in Cash	-4	-10	-1	20	-4	-3	10	-9	57	-10

ProMIS Neurosciences Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Mar 2021	Dec 2021	Dec 2022	Dec 2023	Mar 2025	Dec 2025
Net Income	-4	-7	-7	-5	-9	-18	-13	2	-39,719
Operating Cash Flow	-4	-6	-6	-4	-9	-17	-10	-27	-28,118
Investing Cash Flow	0	0	0	0	0	0	0	0	0
Financing Cash Flow	5	6	5	3	25	6	17	27	20,944
Change in Cash	0	0	0	0	16	-11	6	0	-7,174

Global Institutional Holdings in ProMIS Neurosciences

Check out the Institutions with significant holdings in ProMIS Neurosciences.

Funds	Holdings
Michael Rockefeller	4.93%
Fidelity Concord Street Trust	0.00%
Dimensional	0.00%

Insights on ProMIS Neurosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 699.3% return, outperforming this stock by 720.6%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 117.4% return, outperforming this stock by 197.0%
NEGATIVE IMPACT
Price Dip
In the last 1 month, PMN stock has moved down by -30.3%

About ProMIS Neurosciences

ProMIS Neurosciences, Inc. is a Canadian biotechnology firm dedicated to creating targeted therapeutic solutions for debilitating neurodegenerative conditions such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company leverages a unique computational discovery platform, utilizing its ProMIS and Collective Coordinates algorithms, to identify novel, disease-specific targets – known as epitopes – located on the surface of misfolded proteins. Its pipeline features several promising drug candidates, including PMN310, a monoclonal antibody designed to address toxic oligomers implicated in Alzheimer's disease. Another candidate, PMN267, targets superoxide dismutase 1 and TAR-DNA binding protein 43 in ALS, and alpha-synuclein associated with Parkinson's disease and Lewy body dementia. Finally, PMN442 is a monoclonal antibody aimed at toxic alpha-synuclein oligomers and seeding fibrils relevant to multiple system atrophy. Established in 2004, the company changed its name from Amorfix Life Sciences Ltd. to ProMIS Neurosciences, Inc. in July 2015. Its corporate headquarters are situated in Toronto, Canada.

Organisation	ProMIS Neurosciences
Headquarters	1920 Yonge Street, Toronto, ON, M4S 3E2, CA
Industry	Biotechnology
CEO	Neil K. Warma

Key Management of ProMIS Neurosciences

Name	Title
Dr. Larry Douglas Altstiel M.D., Ph.D.	Chief Medical Officer
Mr. Daniel E. Geffken M.B.A.	Chief Financial Officer
Dr. David Wishart Ph.D.	Chief Physics Officer
Mr. Dennis Chen Ph.D.	Head of Manufacturing & Senior Consultant
Dr. Ivana Rubino Ph.D.	Chief Commercial Officer
Mr. Eugene W. Williams	Co-Founder & Chairman
Mr. Neil K. Warma M.B.A.	CEO, President, Compliance Officer & Director
Dr. Neil R. Cashman M.D.	Co-Founder, Co-Chairman of Scientific Advisory Board, Chief Scientific Officer & Director
Dr. Johanne Kaplan Ph.D.	Chief Development Officer

FAQs

What is ProMIS Neurosciences share price today?

ProMIS Neurosciences share price today is $8.88 as on October 14, 2026 at 1:27 am IST at the close of the market. ProMIS Neurosciences share today touched a day high of $9.47 and a low of $8.51.

What is the 52 week high and 52 week low for ProMIS Neurosciences share?

ProMIS Neurosciences share touched a 52 week high of $27.40 on March 5, 2026 and a 52 week low of $6.27 on November 28, 2025. ProMIS Neurosciences stock price today i.e. October 14, 2026 at 1:27 am IST is closed at $8.88,which is 67.59% down from its 52 week high and 41.63% up from its 52 week low.

What is ProMIS Neurosciences's market capitalisation today?

ProMIS Neurosciences market capitalisation is $0.00T as on October 14, 2026 at 1:27 am IST.

How to invest in ProMIS Neurosciences Stock (PMN) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for ProMIS Neurosciences on INDmoney app. Click on Buy button.

What is the minimum amount required to buy ProMIS Neurosciences Stock (PMN) from India?

Indian investors can start investing in ProMIS Neurosciences (PMN) shares with as little as ₹95.2699966430664 or $1 (as of October 14, 2026 at 4:43 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.70 in ProMIS Neurosciences stock (as per the Rupee-Dollar exchange rate as on October 14, 2026 at 4:43 am IST). Based on ProMIS Neurosciences share’s latest price of $8.88 as on October 14, 2026 at 1:27 am IST, you will get 1.1261 shares of ProMIS Neurosciences. Learn more about fractional shares .